Immunology of carbohydrate-based vaccines.


Journal

Advanced drug delivery reviews
ISSN: 1872-8294
Titre abrégé: Adv Drug Deliv Rev
Pays: Netherlands
ID NLM: 8710523

Informations de publication

Date de publication:
2020
Historique:
received: 03 03 2020
revised: 13 04 2020
accepted: 17 04 2020
pubmed: 23 4 2020
medline: 21 9 2021
entrez: 23 4 2020
Statut: ppublish

Résumé

Carbohydrates are considered as promising targets for vaccine development against infectious diseases where cell surface glycan's on many infectious agents are attributed to playing an important role in pathogenesis. Understanding the relationship between carbohydrates and immune components at a molecular level is crucial for the development of well-defined vaccines. Recently, carbohydrate immunology research has been accelerated by the development of new technologies that contribute to the design of optimum antigens, synthesis of antigens and the studies of antigen-antibody interactions, and as a result, several promising carbohydrate-based vaccine candidates have been prepared in recent years. This article briefly presents the mechanistic pathways of polysaccharide, glycoconjugate, glycolipid and zwitterionic vaccines and the interplay between carbohydrate antigen and immune response.

Identifiants

pubmed: 32320714
pii: S0169-409X(20)30026-0
doi: 10.1016/j.addr.2020.04.006
pii:
doi:

Substances chimiques

Antigens 0
Carbohydrates 0
Glycoconjugates 0
Glycolipids 0
Polysaccharides 0
Vaccines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

117-126

Informations de copyright

Copyright © 2020. Published by Elsevier B.V.

Auteurs

Farjana Khatun (F)

School of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, QLD 4072, Australia; East West University, Dhaka, 1212, Bangladesh.

Istvan Toth (I)

School of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, QLD 4072, Australia; School of Pharmacy, The University of Queensland, Woolloongabba, QLD 4102, Australia; Institute for Molecular Biosciences, The University of Queensland, Woolloongabba, QLD 4072, Australia. Electronic address: i.toth@uq.edu.au.

Rachel J Stephenson (RJ)

School of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, QLD 4072, Australia. Electronic address: r.stephenson@uq.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH